Viskern 5 Mg/Ml Eye Drops Solution 30 Single Dose 0.4 Ml

Viskern (5 Mg / Ml Eye Drops Solution 30 Single Doses 0.4 Ml)

ACTION AND MECHANISM

- Eye lubricant. Carmellose is a highly viscous cellulose derivative, which exerts a lubricating effect by increasing the residence time of the tear on the ocular mucosa.

PHARMACOKINETICS

Ophthalmic route:

- Absorption: due to its high molecular weight (> 90,000 D) its corneal absorption is not expected.

INDICATIONS

- Relief of [EYE DRYNESS] when the eye is subjected to irritants that cause dry eyes and discomfort.

POSOLOGY

- Adults: 1-2 drops in each affected eye, as necessary and at the discretion of the specialist.

- Children and adolescents <18 years: safety and efficacy have not been evaluated.

- Elderly: does not require dosage adjustment.

Missed dose : administer the next dose at the usual time. Do not double the next dose.

DOSAGE IN KIDNEY INSUFFICIENCY

No specific dosage recommendations have been made.

DOSAGE IN LIVER INSUFFICIENCY

No specific dosage recommendations have been made.

RULES FOR CORRECT ADMINISTRATION

Care should be taken to avoid contaminating the eye drops throughout the administration of the drug. To do this, hands should be washed before administration, and the dropper should not come into contact with any surface of the body, including the eyelids and surrounding areas.

"Rules for the administration of eye drops"

1. Tilt your head back.

2. Pull the lower eyelid with an index finger and look up.

3. Instill a drop into the conjunctival sac, keeping the bottle vertical with the dropper pointing down.

4. Once the drop is applied, blink repeatedly to distribute the eye drops. To reduce possible systemic absorption, it is recommended to press the lacrimal sac for one minute or close the eyelids tightly for 2-3 min, immediately after the administration of the eye drops.

If other ophthalmic medications are being used, it is recommended to distance the administrations at least 15 min.

CONTRAINDICATIONS

- Hypersensitivity to carmellose or any other component of the drug.

ADVICE TO THE PATIENT

- Consult your doctor and / or pharmacist if symptoms worsen or do not improve within 72 hours, or if you experience pain, eye irritation or visual disturbances.

INTERACTIONS

No interaction studies have been performed.

PREGNANCY

Animal safety : no data available.

Human Safety : Accepted use, as it is not expected to be absorbed.

Effects on Fertility : No specific studies have been performed in humans.

LACTATION

Animal safety : no data available.

Human Safety : Accepted use, as it is not expected to be absorbed.

KIDS

Safety and efficacy have not been evaluated in children and adolescents under 18 years of age, therefore no dosage recommendations can be made.

SENIORS

No specific problems have been described in the elderly that require a dosage adjustment.

EFFECTS ON DRIVING

Carmellose does not appear to affect the ability to drive significantly. However, like any other drug for ophthalmic administration, blurred vision may appear immediately after use. It is recommended to avoid driving until vision is normal.

ADVERSE REACTIONS

Adverse reactions are described according to each frequency range, being considered very common (> 10%), common (1-10%), uncommon (0.1-1%), rare (0.01-0.1%) , very rare (<0.01%) or of unknown frequency (cannot be estimated from the available data).

- Allergic: infrequent [HYPERSENSITIVITY REACTIONS] local, with [EYE EDEMA] or [EYELID EDEMA].

- Ophthalmological: frequent [EYE IRRITATION], [EYE ITCHING], [EYE PAIN], [TEARING], [BLURRED VISION], [STRANGE BODY SENSATION], [CONJUNTIVAL HYPEREMIA], scabs on the eyelids.

OVERDOSE

Symptoms : symptoms are not expected to appear due to its route of administration and its lack of absorption.

Treatment : not required.

Prospectus Viskern 5 Mg / Ml Eye Drops Solution 30 Single-dose 0.4 Ml